PATENT CLAIM ANALYSIS

Application Number: 15762017
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "561000"]

Abstract:
The present invention relates to methods and compositions used to reduce or prevent organ, tissue and cellular damage induced by irradiation exposure, such as radiodermatitis and radio mucositis. The compositions according to the invention comprise one or more inhibitors of plasminogen or one or more inhibitors of a component of the plasminogen activating pathway.

Claim (Index 11):
The method according to  claim 9  wherein the radiation-induced injury is radiation-induced dermatitis or radiation-induced mucositis.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 90.0
- Lexical Diversity: 1.48718
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['10798119', '11471047', '16086736', '14921758', '13106293']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7414553727397009
- 35 USC 102 Novelty (BERT): 0.5142687654644738
- Combined Prediction Score: 0.7187367120121781
- Mean Citation Score: 183.44773400000005
- Max Citation Score: 209.53464
- Similarity Product: 113.83180895679472

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test